Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
November 29, 2022 16:55 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022
November 28, 2022 16:10 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Participate in November Investor Conferences
November 01, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Participate in September Investor Conferences
August 31, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results
August 10, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference Call on Wednesday, August 10, 2022
August 01, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location
July 26, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Envigo Reaches Agreement with the U.S. Department of Justice and the U.S. Department of Agriculture to Resolve Civil and Administrative Complaints
July 18, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 18, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc.
July 07, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 07, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Glenn Washer Joins Inotiv, Inc., as Group President, Safety Assessment
June 22, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 22, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...